ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $49,000 | -76.1% | 75,584 | -59.8% | 0.00% | – |
Q4 2021 | $205,000 | -83.5% | 188,231 | -72.4% | 0.00% | -100.0% |
Q3 2021 | $1,243,000 | +82.0% | 683,102 | +164.2% | 0.00% | – |
Q2 2021 | $683,000 | +48.5% | 258,589 | +102.5% | 0.00% | – |
Q1 2021 | $460,000 | +146.0% | 127,693 | +72.5% | 0.00% | – |
Q4 2020 | $187,000 | +87.0% | 74,033 | +86.9% | 0.00% | – |
Q3 2020 | $100,000 | -32.4% | 39,614 | -12.4% | 0.00% | – |
Q2 2020 | $148,000 | +15.6% | 45,241 | -13.6% | 0.00% | – |
Q1 2020 | $128,000 | -39.9% | 52,359 | +16.0% | 0.00% | – |
Q4 2019 | $213,000 | +33.1% | 45,153 | +20.8% | 0.00% | – |
Q3 2019 | $160,000 | -1.8% | 37,387 | +33.5% | 0.00% | – |
Q2 2019 | $163,000 | +68.0% | 28,011 | +10.7% | 0.00% | – |
Q1 2019 | $97,000 | +67.2% | 25,308 | -18.0% | 0.00% | – |
Q4 2018 | $58,000 | -14.7% | 30,877 | +46.1% | 0.00% | – |
Q3 2018 | $68,000 | -60.5% | 21,129 | -62.9% | 0.00% | – |
Q2 2018 | $172,000 | -10.9% | 56,934 | +15.8% | 0.00% | – |
Q1 2018 | $193,000 | -76.7% | 49,187 | -75.4% | 0.00% | -100.0% |
Q4 2017 | $827,000 | +57.5% | 199,677 | +133.4% | 0.00% | 0.0% |
Q3 2017 | $525,000 | -1.5% | 85,569 | -0.1% | 0.00% | 0.0% |
Q2 2017 | $533,000 | +3.7% | 85,676 | +5.8% | 0.00% | 0.0% |
Q1 2017 | $514,000 | +403.9% | 81,011 | +325.7% | 0.00% | – |
Q4 2016 | $102,000 | -2.9% | 19,032 | +2.3% | 0.00% | – |
Q3 2016 | $105,000 | -80.5% | 18,600 | -81.0% | 0.00% | -100.0% |
Q2 2016 | $538,000 | +214.6% | 97,985 | +325.2% | 0.00% | – |
Q1 2016 | $171,000 | -2.8% | 23,042 | +8.9% | 0.00% | – |
Q4 2015 | $176,000 | -18.9% | 21,152 | -12.0% | 0.00% | – |
Q3 2015 | $217,000 | -15.6% | 24,045 | +12.2% | 0.00% | -100.0% |
Q2 2015 | $257,000 | -63.4% | 21,431 | -67.2% | 0.00% | 0.0% |
Q1 2015 | $703,000 | +66.2% | 65,320 | -21.7% | 0.00% | 0.0% |
Q4 2014 | $423,000 | +93.2% | 83,400 | +0.4% | 0.00% | – |
Q3 2014 | $219,000 | -37.8% | 83,053 | -4.8% | 0.00% | -100.0% |
Q2 2014 | $352,000 | -56.7% | 87,220 | -50.9% | 0.00% | -50.0% |
Q1 2014 | $813,000 | +44.9% | 177,521 | +37.3% | 0.00% | +100.0% |
Q4 2013 | $561,000 | +87.6% | 129,307 | +70.3% | 0.00% | 0.0% |
Q3 2013 | $299,000 | +251.8% | 75,951 | +89.1% | 0.00% | – |
Q2 2013 | $85,000 | – | 40,161 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |